Healthcare Interoperability Market to Hit $21.5B by 2030 as AI Spending Forces Data Upgrades
Allied Market Research projects interoperability spending will quadruple to $21.54 billion by 2030 at 14.9% CAGR. Public health AI initiatives and tightening ONC/CMS compliance windows are converting integration from cost center to budget prerequisite.
Market Growth Reframes Interoperability as Discrete Budget Category
Healthcare interoperability spending will grow from $6.20 billion in 2021 to $21.54 billion by 2030, according to Allied Market Research's latest forecast. The 14.9% compound annual growth rate signals that data exchange is no longer a side-item integration expense—it is becoming a standalone procurement category with sustained double-digit expansion.
For enterprise buyers, this growth trajectory creates three immediate pressures. Entrenched vendors like Epic Systems, Oracle Cerner, and InterSystems will have pricing power as demand outpaces IT budget growth. Business cases for multi-year integration projects can now be justified against a $21.5 billion addressable market rather than treated as one-off compliance costs. The market segmentation data provides benchmarks for comparing vendor pricing and scope against industry norms instead of relying on isolated quotes.
The forecast includes biomedical device integration platforms like Philips Capsule MDIP alongside traditional EHR vendors, meaning device data and clinical system exchange now compete for the same budget dollars. Smaller integration specialists—OSP Labs, ViSolve, CES Limited—appear in the competitive set despite EHR consolidation, indicating room for specialized platforms that can move data between disparate systems faster than monolithic vendors.
AI Spending Converts Interoperability from Compliance to Enabler
Public health agencies operating under budget constraints are being told that artificial intelligence tools for outbreak detection and Medicaid analytics cannot function without modern data exchange infrastructure. A March 2026 policy analysis presented to state and local officials frames interoperability as a prerequisite for accessing new federal AI funding streams, not an optional add-on.
This positioning changes procurement dynamics. Buyers in public health, state Medicaid programs, and payer organizations now face RFPs that combine FHIR/HL7 interoperability requirements with AI-ready data lake and governance specifications in single procurements. Vendors that demonstrate both multi-source data ingestion and machine learning capabilities gain an advantage over those offering only integration or only analytics.
The shift creates real budget risk for organizations that defer interoperability upgrades. Failing to modernize data exchange may disqualify agencies from AI pilots and grants, which carries both financial and political consequences. Interoperability vendors with public health agency references and documented CDC/ONC standards compliance are positioned to capture procurement tied to these funding programs.
Compliance Timelines and Safety Data Tighten Implementation Windows
Recent legal and governance commentary is highlighting escalating risks from poor interoperability implementations. ISACA reports that more than 50% of EHR deployments have failed, with 18,000 EHR-related patient safety events documented. Those failures increasingly stem from data interoperability and workflow misalignment rather than user interface problems.
The ONC nationwide interoperability roadmap ties exchange milestones to payment reforms and certification programs, but the enforcement climate around those requirements is tightening. TEFCA and API interoperability mandates from ONC and CMS carry potential payment penalties or program exclusions for organizations that cannot exchange data appropriately. For buyers, this creates compressed implementation windows—vendors must demonstrate not just technical compliance but also workflow integration that reduces safety event risk.
The combination of market growth, AI-driven budget justification, and tightening compliance creates a vendor consolidation dynamic. Large health systems will gravitate toward Epic, Oracle Cerner, and InterSystems for risk mitigation despite higher costs. Ambulatory and payer buyers will evaluate NextGen Healthcare and Veradigm for analytics-integrated exchange. Public sector and cross-jurisdictional buyers will prioritize platforms with demonstrated CDC/ONC compliance and multi-source ingestion.
What to Watch
Track how vendors bundle interoperability with AI and analytics capabilities in upcoming product announcements. Platforms that cannot demonstrate both will lose ground in consolidated procurements. Monitor federal funding program requirements for AI pilots—interoperability specifications in those RFPs will set de facto standards for public sector buying. Watch for pricing increases from Epic, Oracle Cerner, and InterSystems as the 14.9% CAGR gives them leverage in contract renewals. Organizations with integration budgets still scattered across departments should consolidate spending now to gain negotiating power before vendor pricing adjusts to market growth projections.
Technology decisions, clearly explained.
Weekly analysis of the tools, platforms, and strategies that matter to B2B technology buyers. No fluff, no vendor spin.
